KYinno Biotechnology

Beijing, China · Founded 2017 · Privately Held (backing)

Developer of oncology drugs intended to accelerate cancer drug discovery and development. KYinno Biotechnology is based in Beijing, China and was founded in 2017. Its last reported valuation was $68.3 million in Oct 2021. It has raised $59 million.

Last reported valuation
$68.3M
Oct 2026
Priced at
—
Total raised
$59.0M
Last round
—

Who backs KYinno Biotechnology?

9 investors
InvestorType
Beijing State-owned Capital Operation and ManagementOther
Renai CapitalOther
BioTrack Capital—
China Everbright—
Guochun Li—
MPC (Beijing)—
Shengyi Jiang—
YSHC Ventures—
Yizhuang Guotou—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

KYinno Biotechnology investors

9 investors are on record for KYinno Biotechnology, including Beijing State-owned Capital Operation and Management, Renai Capital, BioTrack Capital and China Everbright.

Free account
More of KYinno Biotechnology with a free account
  • ·Watch KYinno Biotechnology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like KYinno Biotechnology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View